-
Brugia Rapid Test is recommended for use in the Global Programme to Eliminate Lymphatic Filariasis (GPELF)
-Circulating microfilariae can be detected by examining thick smears (20–60 μl) of finger-prick blood. Blood must be collected at a specific time – either at night or during the day – depending on the periodicity of the microfilariae. The method is inexpensive and feasible at individual and community levels for mapping the endemicity of lymphatic filariasis and monitoring mass drug administration (MDA).
00 -
Product Training and Demonstration of PanLF and Brugia Rapid Test for Transmission Assessment Survey (TAS) Program for Ministry of Health, Malaysia
-On 10th July 2017, Reszon Diagnostics International Sdn Bhd (Reszon) was invited by the Ministry of Health Malaysia to conduct product training and demonstration of PanLF Rapid Test and Brugia Rapid Test.
-
PanLF Rapid Test and Brugia Rapid Test in GPELF Program
-The Global Program to Eliminate Lymphatic Filariasis (GPELF) was initiated by WHO since year 2000 with the ultimate objectives to stop the spread of filariasis infection and to control morbidity through continuous collaborative effort worldwide.
Posts tagged with ‘GPELF’
Reszonics > GPELF